Emotra AB (publ) announced earnings results for the first quarter ended March 31, 2017. For the quarter, the company reported operating loss of SEK 1,861,000 against SEK 1,428,000 a year ago. Loss before taxes was SEK 1,861,000 against SEK 1,830,000 a year ago. Net loss of the period was SEK 1,822,000 or SEK 0.19 diluted per share against SEK 1,391,000 or SEK 0.15 diluted per share a year ago. The larger operating loss is due in its entirety to increased costs to compensate the participating clinics for their costs of participating in their clinical study, EUDOR-A.